Cannabis Bioscience International Holdings ( (CBIH) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cannabis Bioscience International Holdings has filed a Form 12b-25, indicating a delay in filing its Form 10-Q (Quarter Report) for the financial period ending August 31, 2025. The primary reason for the delay is the inability to analyze and complete the financial information on time. The company anticipates filing the report within five calendar days following the prescribed due date. Financially, the company expects a significant change in results, with an estimated loss from operations of approximately $66,000 for the three months ended August 31, 2025, compared to a loss of $97,604 for the same period in 2024. Revenues and gross profit are also expected to decrease significantly. Cannabis Bioscience International Holdings is actively working towards compliance, with the notification signed by CEO Dante Picazo.
More about Cannabis Bioscience International Holdings
Current Market Cap: $5.23M
See more insights into CBIH stock on TipRanks’ Stock Analysis page.